India, March 5 -- Auro Vaccines, a wholly owned step-down subsidiary of Aurobindo Pharma, has today, 05 March 2025, terminated the License Agreement (entered on 27 September 2023) with Hilleman Laboratories Singapore to develop, manufacture and commercialize a pentavalent vaccine candidate used in children vaccination.
Published by HT Digital Content Services with permission from Pivotal Sources....